Big U.S. pharmacies square off on Daraprim supplies

December 18, 2015 6:39 AM

35 0

Big U.S. pharmacies square off on Daraprim supplies

As Turing Pharmaceuticals Chief Executive Officer Martin Shkreli contends with charges of securities fraud, major U.S. pharmacies are moving to assure patients of continued access to the company's key drug, Daraprim.

Shkreli was arrested on Thursday for engaging in what U.S. prosecutors said was a Ponzi-like scheme at his former hedge fund and a pharmaceutical company he previously headed. Turing officials did not respond to multiple requests for comment on the company's future plans regarding Shkreli or its dru...

Also read: Synergy Pharma's irritable bowel drug succeeds in key study

Read more

To category page

Loading...